Chinese immuno-oncology play CStone raises $260M

CStone Pharmaceuticals Co. Ltd. (Suzhou, China) raised $260 million in a series B round led by new investor GIC Private. CStone said the

Read the full 237 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE